Pacira Pharmaceuticals (PCRX) PT Lowered to $40 at Barclays
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.24 +1.04%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Barclays analyst Balaji Prasad lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $40.00 (from $50.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
- LG Electronics India (LGEL:IN) PT Raised to INR1,983 at Nomura/Instinet
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
